Bladder Cancer Symptoms
The Food and Drug Administration’s warning about Actos stated that patients who used the drug for more than one year or who were treated with the highest doses are at an increased risk of developing bladder cancer. According to the Actos warning label, patients who use the drug for more than one year are 40% more likely to be diagnosed with bladder cancer than those who used other diabetes drugs.
The FDA’s Actos warning stated that patients who are taking the drug should be alert for symptoms of bladder cancer, which may be an early indication that they have developed the disease. These symptoms can include:
- Blood in the urine (including dark colored urine)
- Frequent urination
- Urgent need to urinate
- Urinary tract infections
- Lower back pain
- Abdominal pain
In most cases, bladder cancer is detected early and can be treated effectively. However, because patients who have undergone bladder cancer treatment frequently experience a recurrence of the disease, follow up testing is routinely performed in order to look for signs of returning cancer.
The FDA has advised patients who have developed any of the symptoms of bladder cancer or who are concerned about their risk of developing the disease to talk with their doctors. Because of the increased risk of the disease that it may cause, the agency has also advised patients who are being treated for bladder cancer not to take Actos.
If you or a loved one used Actos and were diagnosed with bladder cancer—or have developed symptoms of the disease—you may be eligible to file a lawsuit. For a free legal evaluation of your rights, contact the lawyers at Hissey Kientz, LLP by calling 1-866-275-4454, or by filling out the free case evaluation form located on this page.